REQUEST A DEMO
Total
USD $0.00
Search more companies

Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. is based in Colombia. The head office is in Medellin. The enterprise operates in the Diagnostic Imaging Centers industry. The enterprise was incorporated on February 22, 2010. It currently has a total number of 207 (2024) employees. From the latest financial highlights, Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. reported a net sales revenue increase of 16.6% in 2023. Its’ total assets recorded a growth of 60.34%. The net profit margin of Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. increased by 4.03% in 2023.

Headquarters
Calle 49 No. 45-81 Piso 3.
Medellin; Antioquia;

Contact Details: Purchase the Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. report to view the information.
Outstanding Shares:
Purchase the Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. report to view the information.
Incorporation Date:
February 22, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Adilab-Ayudas Diagnosticas y Laboratorio Clinico S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.6%
Total operating revenue
16.6%
Operating profit (EBIT)
37.41%
EBITDA
-11.8%
Net Profit (Loss) for the Period
136.35%
Total assets
60.34%
Total equity
32.45%
Operating Profit Margin (ROS)
2.03%
Net Profit Margin
4.03%
Return on Equity (ROE)
11%
Debt to Equity Ratio
8.77%
Quick Ratio
-0.74%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?